期刊文献+

PCR-SSCP检测急性髓系白血病患者FLT3基因及FLT3/ITD基因突变 被引量:3

The detection of FLT3 and FLT3/ITD gene mutation by polymerasechain reaction single-strand conformation polymophism in acute myeloid leukemia patients
下载PDF
导出
摘要 目的研究急性髓系白血病(AML)患者DNA水平FLT3基因及其内部串联重复(ITD)突变。方法采用多聚酶链反应(PCR)联合单链构象多态性(SSCP)方法检测43例不同免疫分型AML患者DNA水平FLT3基因及FLT3/ITD基因突变。结果43例AML患者经PCR扩增,琼脂糖凝胶电泳FLT3基因检测全部阳性,未发现FLT3/ITD基因突变;SSCP电泳FLT3基因检测全部阳性,43例AML患者中有15例(35%)出现FLT3/ITD基因突变。结论PCR-SSCP适用于检测急性髓系白血病FLT3/ITD基因突变分析。 Objective To study the FLT3 gene expression and its internal tandem duplication ( ITD)mutation in acute myeloid leukemia (AML) patients.Methods Polymerase chain reaction (PCR)and single strand conformation polymophism (SSCP) were used to detect FLT3 gene and FL T3/1TD mutation in 43 AML patients. Results The expression of FL 33 gene were detected in 43 AML patients with agarose gel and single-strand conformation polymorphism eletrophoresis;There was no FLT3/ITD mutation withagamse gel eletrophoresis, but FLT3/1TD mutation was detected in 15 cases (35%)with single-strand conformation polymorphism gel eletrophoresis. Condttsion PCR-SSCP was suitable to detected FLT3/ITD mutation in acute myeloid leukemia (AML) patients.
出处 《中国实验诊断学》 北大核心 2009年第8期1090-1092,共3页 Chinese Journal of Laboratory Diagnosis
关键词 急性髓系白血病 FLT3基因 FLT3/ITD基因突变 多聚酶链反应 acute myeloid leukemia FLT3 gene FLT3/ITD mutation Polymerase chain reaction(PCR)
  • 相关文献

参考文献7

  • 1Mathews W, Jordan CT, Wiegand GW, et al. A receptor tyrosine kinase specific to haematopoietic stem and progenitor cell-enriched populations [J]. Cell, 1991,65: 1143.
  • 2Stirewalt DL, Radich J P. The role of FL T3 in haematopoietic malignancies[ J]. Nat Rev Cancer, 2003,3 : 650.
  • 3Kiyoi H, Naoe T, Nakano Y, et al. Prognostic implication of FLT3and N2RAS gene mutations in acute myeloid leukemia[ J]. Blood, 1999,93: 3074.
  • 4Kiyoi H, Towatari M, Yokota S, et al. Internal tandem duplicationof the FLT3 gene is a novel modality of elongation mutation which causes constitutive activation of the product[J]. Leukemia, 1998,12:1333.
  • 5Kainz B, Heintel D, Marculescu R, et all Variable prognostic value ofFLT3 internal tandem duplications in patientswith de novo AML anda normal karyotype,t(15;17),t(8;21) or inv (16) 1[J].Hematol J,2002,3:283.
  • 6Nakao M,Janssen JW,Erz D,et al. Tandem duplication of the FLT3 gane in acute lymphoblastic leukemia: a marker for the monitoring of minimal residual disease[ J ]. Leukemia, 2000,14: 522.
  • 7Ciolli S, Vannucchi AM, Leoni F, et all Internal tandem duplicationsof FLT3 gene (FLT3/ITD) predicts a poor postremission outcome inadult patients with acute non-promyelocytic leukemialLeuk Lymphoma,2004, .45:73 - 78.

同被引文献36

  • 1应逸,陈建兰,王汉平,谢健晋,周薇,陈小卫,陈小燕.急性髓细胞白血病NPM1和FLT3-ITD突变检测临床意义分析[J].中华肿瘤防治杂志,2013,20(2):121-124. 被引量:6
  • 2王莉红,周春林,张新伟,陈森,王敏,王建祥.FLT3基因内部串联重复突变与急性白血病的关系及临床意义[J].中华血液学杂志,2004,25(7):393-396. 被引量:35
  • 3Gale RE,Hills R,Kottardis PD,et al.No evidence that FLT3 status should be considered as an indicator for transplantation in acute myeloid leukemia(AML):an analysis of 1135 patients,excluding acute promyelocytic leukemia,from the UK MRC AML 10 and 12 trials[J].Blood,2005,106:3658-3665.
  • 4Schlenk RF,Dohner K,Krauter J,et al.Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia[J].N Engl J Med,2008,358:1909-1918.
  • 5Pratz KW,Sato T,Murphy KM,et al.FLT3-mutant allelic burden and clinical status are predictive of response to FLT3 inhibitors in AML[J].Blood,2010,115:1425-1432.
  • 6Breitenhuecher F,Markova B,Kasper S,et al.A novel molecular mechanism of primary resistence to FLT3-kinase inhibitors in AML[J].Blood,2009,113 (17):4063-4073.
  • 7A1 Shaer L,Walsby E,Gilkes A,et al.Heat shock protein 90 inhibition is cytotoxic to primary AML cells expressing mutant FLT3 and results in altered downstream signaling[J].Br J Haematol,2008,141 (4):483-493.
  • 8Nishioka C,Ikezoe T,Yang J,et al.MS-275 a novel histone deacetylase inhibitor with selectivity against HDACI,induces degradation of FLT3 via inhibition of chaperone function of heat shock protein 90 in AML cells[J].Leuk Res,2008,32(9):1382-1392.
  • 9Zeng Z,Shi YX,Samudio IJ,et al.Targeting the leukemia microenvironment by CXCR4 inhibition overcomes resistance to kinase inhibitors and chemotherapy in AML[J].Blood,2009,113(24):6215-6224.
  • 10Griffith J,Back J,Faerman C,et al.The structural basis for auto inhibition of FLT3 by the juxtamembrane domain[J].Mol Cell,2004,30:169-178.

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部